Bosutinib is a small molecule tyrosine kinase inhibitor used as an active pharmaceutical ingredient in pharmaceutical manufacturing. It is primarily supplied for research and development purposes in the context of oncology drug studies.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 380843-75-4
11-hydroxy-N-methyldesloratadine
pharmaceutical raw material
Perampanel
pharmaceutical raw material
Oglufanide
pharmaceutical raw material
Decamethoxin hydrochloride
pharmaceutical raw material
4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile
UBPYILGKFZZVDX-UHFFFAOYSA-N
CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC